Acarizax, Lyophilisat zum Einnehmen
7680658230016
CH-65823
Lyophilisat
Associated product:
ACARIZAX Lyophilisat oral 12 SQ-HDM 30 pce
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Einzeldose(n)
- Galenic form
- Lyophilisat
- Galenic group
- Lösbar zur Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
12.0 U | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
12.7 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
0.14 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 100.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2016
Authorization holder
ALK-Abelló AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 65823
- Drug name
- Acarizax, Lyophilisat zur sublingualen Anwendung
- Galenic form
- LYSUV
- ATC Code
- V01AA03
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 24/08/2016
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.13.3.
- Domain
- Human medicine
Package details
- Description (FR)
- ACARIZAX Lyophilisat oral 12 SQ-HDM 30 pce
- Description (DE)
- ACARIZAX Lyophilisat oral 12 SQ-HDM 30 Stk
- Market launch
- 24/08/2016
- Narcotic (BTM)
- No
Other package sizes (1)
ACARIZAX Lyophilisat oral 12 SQ-HDM 90 pce
90 EINZ
GTIN: 7680658230023